Literature DB >> 2536950

Pharmacological studies of lappaconitine. Occurrence of analgesic effect without opioid receptor.

M Ono1, T Satoh.   

Abstract

The contribution of opioid receptor to lappaconitine (LA) induced analgesia was investigated by in vivo and in vitro methods. The antagonistic effects of naloxone (NLX) on the analgesic actions of LA (s.c.) and morphine (MOR, s.c.) were determined by the tail pressure method, the hot plate method and the acetic acid-induced writhing method in mice. The ED50 values of MOR in the absence of NLX were 3.82, 0.50 and 0.33 mg/kg, respectively, but in the presence of NLX, the analgesic effect of MOR was decreased and the ED50 values were changed to 41.6, 4.40 and 5.97 mg/kg, respectively. However, NLX did not affect the analgesic activity of LA. The ED50 values of LA in the three methods were 9.12, 3.34 and 1.70 mg/kg in the absence of NLX and 12.1, 4.19 and 2.88 mg/kg in the presence of NLX, respectively. The inhibitory effect of the LA on the electrically evoked contractions of isolated guinea-pig ileum was weaker than that of MOR, and differently from MOR, its effect was not antagonized by NLX. Additionally, LA did not abolish the electrically evoked contractions of isolated rabbit and mouse vas deferens. In conclusion, the results suggest that the opioid receptor was not involved in the analgesic activity of LA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536950

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  6 in total

1.  Frequency-dependent inhibition of neuronal activity by lappaconitine in normal and epileptic hippocampal slices.

Authors:  A Ameri; P Metzmeier; T Peters
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Lappaconitine, a C18-diterpenoid alkaloid, exhibits antihypersensitivity in chronic pain through stimulation of spinal dynorphin A expression.

Authors:  Ming-Li Sun; Jun-Ping Ao; Yi-Rui Wang; Qian Huang; Teng-Fei Li; Xin-Yan Li; Yong-Xiang Wang
Journal:  Psychopharmacology (Berl)       Date:  2018-06-20       Impact factor: 4.530

3.  Clinical Effects from Ingestion of Lappaconitine, an Aconitum Alkaloid with Sodium Channel Blocking Effects.

Authors:  Daniel J McCabe
Journal:  J Med Toxicol       Date:  2022-05-13

4.  Inhibitory effects of lappaconitine on the neuronal isoforms of voltage-gated sodium channels.

Authors:  Yan-Fen Li; Yue-Ming Zheng; Yong Yu; Yong Gan; Zhao-Bing Gao
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

5.  Analgesic effects of lappaconitine in leukemia bone pain in a mouse model.

Authors:  Xiao-Cui Zhu; Chen-Tao Ge; Pan Wang; Jia-Li Zhang; Yuan-Yang Yu; Cai-Yun Fu
Journal:  PeerJ       Date:  2015-05-07       Impact factor: 2.984

6.  Hybrides of Alkaloid Lappaconitine with Pyrimidine Motif on the Anthranilic Acid Moiety: Design, Synthesis, and Investigation of Antinociceptive Potency.

Authors:  Kirill P Cheremnykh; Victor A Savelyev; Sergey A Borisov; Igor D Ivanov; Dmitry S Baev; Tatyana G Tolstikova; Valentin A Vavilin; Elvira E Shults
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.